Article | July 25, 2017

Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

One area of great interest concerns the use of a patient’s own cells to treat the disease they are suffering from, which is also known as autologous cell therapy. The ability to administer stem cell therapies at the bedside would facilitate and expedite treatment, translating to an even more remarkable impact on some of the world’s most affected patient populations.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Thermo Fisher Scientific Bioproduction